Hatfield, PA, United States of America

Mark G Bock


 

 

Average Co-Inventor Count = 3.5

ph-index = 20

Forward Citations = 1,244(Granted Patents)

DiyaCoin DiyaCoin 1.19 


Inventors with similar research interests:


Location History:

  • Hatfield,, PA (US) (1985)
  • Rahway, NJ (US) (1998)
  • Cambridge, MA (US) (2012 - 2014)
  • Hatfield, PA (US) (1979 - 2018)
  • Boston, MA (US) (2012 - 2022)

Company Filing History:


Years Active: 1979-2022

where 'Filed Patents' based on already Granted Patents

104 patents (USPTO):

Title: Mark G Bock - Innovator Extraordinaire in the Field of Medical Science

Introduction:

Mark G Bock, a brilliant mind in the medical science arena, has achieved remarkable milestones throughout his illustrious career. With a knack for innovation and a keen focus on pushing technological boundaries, Bock has garnered recognition and praise from industry experts and peers alike. This article delves into his latest patents, remarkable career highlights, and notable collaborations.

Latest Patents:

Bock's contributions to the field of medical science are exemplified by his latest patents. Among them are two promising inventions that hold significant potential for the treatment of various diseases.

1. PPAR agonists:

Bock's patent showcases compounds and compositions designed to increase PPARδ (peroxisome proliferator-activated receptor delta) activity. This innovative invention offers potential therapeutic applications in combating PPARδ-related diseases, including muscular diseases, vascular disease, demyelinating disease, and metabolic diseases.

2. Glycoside derivatives and uses thereof:

Another groundbreaking invention by Bock is represented by compounds, as per formula (I), which exhibit the potential to treat diseases mediated by the sodium D-glucose co-transporter (SGLT), specifically diabetes. Bock's patent also includes methods and compositions for effectively treating such diseases and conditions.

Career Highlights:

Throughout his career, Bock's inventive mind has left an indelible mark on the medical science landscape. With over 104 patents to his name, Bock has made significant contributions to the field. His work has been cherished for its potential to revolutionize various domains within medical science.

Collaborations:

Bock's commitment to innovation and his desire to make a difference have often led to successful collaborations with notable industry peers. Among the talented individuals he has worked with are Roger M Freidinger and Ben E Evans. These collaborations have fostered an environment of shared expertise, leading to groundbreaking advancements in their respective fields.

Conclusion:

Mark G Bock's career in medical science serves as a testament to his unwavering dedication to innovation and pushing technological boundaries. His notable patents, including those related to PPAR agonists and glycoside derivatives, highlight his expertise in addressing critical healthcare challenges. Through collaborations with esteemed colleagues, Bock has further amplified the impact of his inventive contributions. As Bock's journey continues, it is certain that his pioneering spirit will continue to shape the future of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…